On Wednesday, Amazon disclosed that it has spent $2.12 billion on its own shares so far this year, and must like how it is going: The board ripped up the $5 billion authorization before it was half spent and replaced it with a $10 billion fund, with no expiration date. Read More...
Motley Fool
Why Moderna Stock Was a Big Winner on Wednesday
In the wake of that announcement, the biotech company’s stock price shot more than 10% higher for the session. This happy investor is Josh Brown, a high-profile financial writer, blogger, and CNBC commentator, who revealed that he’d bought Moderna stock at what he termed a “ludicrous” price of $125 per share. In an interview that aired on CNBC, Brown asserted that Moderna has far more value than its recent share prices would indicate.
Add Comment